We proudly present our Confirmed Speakers

Plenary Speakers

Alzheimer Treatment:  Past, present and future

Brain Dimensions of Depression: From Biomarkers to Home-Based Neuromodulation

Ricardo F. Allegri

Prof. Ricardo F. Allegri

Professor of Neurology
School of Medicine, Universidad de Buenos Aires

Head of Department of Cognitive Neurology, Neuropsychology and Neuropsychiatry, Instituto de Investigaciones Neurológicas Fleni

Buenos Aires, Argentina

Bio Ricardo F. Allegri
Cynthia Fu

Prof. Cynthia Fu

Professor of Affective Neuroscience

Director, Affective Clinical Neuroscience Unit, Department of Psychology and Human Development, University of East London

London, United Kingdom

Bio Cynthia Fu

Debate Speakers

Cannabis use in adolescence negatively impacts emerging adults' neurodevelopmental and cognitive abilities’

Sir Robin Murray

Proponent

Prof. Robin Murray

Professor of Psychiatric Research 
Institute of Psychiatry, Psychology and Neuroscience
King’s College


London, United Kingdom

Bio Robin Murray
Debasish Basu

Opponent

Dr. Debasish Basu

Former Professor and Head
Department of Psychiatry,
Postgraduate Institute of Medical Education & Research (PGIMER)

Chandigarh, India

Bio Debasish Basu

Are GLP-1 receptor agonists the new frontier in the treatment of psychiatric disorders?

Dan Siskind

Proponent

Prof. Dan Siskind

Professor
University of Queensland,
Faculty of Health, 
Medicine and Behavioural Science


Brisbane, Australia

Bio Dan Siskind
Andreas Reif

Opponent

Prof. Andreas Reif

Chair
Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, 
University Medical Centre Frankfurt

Frankfurt, Germany

Bio Andreas Reif

Immuno-metabolic depression: Is it prime time to adopt immuno-metabolic modulating pharmacological and lifestyle interventions?

Prof. Jane A. Foster

Proponent

Prof. Jane A. Foster

Professor
Center for Depression Research and Clinical Care, 
Division of General Psychiatry, 
UT Southwestern Medical Center

Dallas, United States

Bio  Jane Foster
Prof. Gin S. Malhi

Opponent

Prof Gin S. Malhi 

School of Psychiatry, 
University of New South Wales

Sydney, Australia

Bio Gin S. Malhi 

State-of-the-Art Session Speakers

Advances in Psychosis: Real Advances and Chimeras Over the Past Half-Century

Cognitive neuroscience of antidepressant action- what’s new and why does it matter?

Sir Robin Murray

Prof. Robin Murray

Professor of Psychiatric Research 
Institute of Psychiatry, Psychology and Neuroscience,
King’s College


London, United Kingdom

Bio Robin Murray
Catherine Harmer

Prof. Catherine Harmer

Professor of Cognitive Neuroscience

Associate Head of Department People & Culture,
University of Oxford
Warneford Hospital

Oxford, United Kingdom

Bio Catherine Harmer

Presidential Symposium Speakers

Beyond DSM-5: What Comes Next—and Why It Matters’ or ‘The Future of Diagnosis: Inside the Next DSM

Anissa Abi-Dargham

Prof. Anissa Abi-Dargham

Chair
Psychiatry and Behavioral Health
Stony Brook Medicine 


New York, United States

Bio Anissa Abi-Dargham
Nitin Gogtay

Nitin Gogtay, MD 

VP
Division of Research
Deputy Medical Director

American Psychiatric Association

Bethesda, United States

Bio Nitin Gogtay 

Drug Pipeline Symposium Speakers

Ravi Anand

Ravi Anand, MD

Chief Medical Officer 
Newron Pharmaceuticals SpA 

Bresso, Italy

Bio Ravi Anand
Pablo Lapuerta

Pablo Lapuerta, MD

Founder and CEO 
4M Therapeutics

Princeton, United States

Bio Pablo Lapuerta

Further confirmed speakers will be announced shortly.

Get our Newsletter and stay informed

Subscribe